ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

<p>MiNK Therapeutics combines its unique, proprietary library of T-cell antigens with ImmunoScape’s cutting-edge platform for rapid discovery of novel T-cell receptors Therapeutic development to focus on novel cell therapies as well as bispecific immune cell engagers against solid tumors SAN DIEGO and NEW YORK and SINGAPORE, Dec. 20, 2023 (GLOBE NEWSWIRE) — ImmunoScape, a biotechnology […]</p>
<p>The post <a href="https://forextv.com/top-news/immunoscape-and-mink-therapeutics-collaborate-to-accelerate-novel-tcr-identification-and-therapeutic-development/">ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>